ENWEI PHARMACEUTICAL released its first-quarter performance, with a net profit attributable to the parent company of 16.31 million yuan, a year-on-year increase of 93.56%
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, ENWEI PHARMACEUTICAL disclosed its first-quarter report for 2025, showing that the company achieved revenue of 196 million yuan during the reporting period, a year-on-year increase of 7.10%; net profit attributable to the parent company was 16.31 million yuan, a year-on-year increase of 93.56%; and net profit excluding non-recurring gains and losses was 14.62 million yuan, a year-on-year increase of 118.93%. The basic earnings per share were 0.1635 yuan
According to the Zhitong Finance APP, ENWEI PHARMACEUTICAL (301331.SZ) disclosed its first-quarter report for 2025. During the reporting period, the company achieved revenue of 196 million yuan, a year-on-year increase of 7.10%; net profit attributable to the parent company was 16.31 million yuan, a year-on-year increase of 93.56%; and net profit excluding non-recurring gains and losses was 14.62 million yuan, a year-on-year increase of 118.93%. The basic earnings per share were 0.1635 yuan